Zylox-Tonbridge Medical Swings to Profit in 2024 as Revenue Jumps 48%
MT Newswires Live03-21
Zylox-Tonbridge Medical Technology (HKG:2190) reported a profit attributable to shareholders of 100.3 million yuan for 2024, rebounding from a loss of 78.7 million yuan in the previous year.
Earnings per share were 0.3057 yuan, according to a Thursday filing with the Hong Kong bourse.
Revenue for the year rose 48% to 782.5 million yuan from 527.8 million yuan in the prior year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.